Inclusion Criteria:
  -  Diagnosis of glomerulonephritis (MCD, FSGS, MN, IgAN, RPGN, lupus nephritis and etc.) on first diagnostic kidney biopsy, as per specified pathology definitions
  -  First diagnostic kidney biopsy since 2010
  -  Willingness to comply with study requirements, including intention to fully participate in protocol-specified follow-up at a clinical study site
  -  Informed consent and, where age appropriate, informed assent (clinical data, human derived materials including genomic data)
Exclusion Criteria:
  -  Unwillingness to give informed consent
  -  Not enough kidney tissue to confirm a diagnosis (adequate tissue: more than 2 cores of kidney tissues (10 x 1.2 mm) including over 10-15 glomerulus each)